Targeting cytokine and chemokine signaling pathways for cancer therapy.
Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. · 2024
Read Targeting cytokine and chemokine signaling pathways for cancer therapy. by Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11275440.txt.
Introduction
Yi and colleagues review signal proteins as targets for cancer therapy in this 2024 paper. Cytokines are proteins that regulate immune responses and cell behaviour. Families include interleukins, interferons, tumour necrosis factors, and chemokines, which guide cell movement. Growth factors such as TGF-beta, VEGF, and EGF belong to the same broad set. These molecules can push tumours either way.
Depending on context, a cytokine can promote or suppress tumour growth, the authors stress. It can also reshape the tumour's surroundings and change how well treatments work. Recent agents aim to modulate these pathways to slow progression and beat resistance. The review summarises current understanding of each family in tumour biology. It then details the new drugs built on that knowledge. The dual nature of cytokines is treated as both the central challenge and the central opportunity.
Catalog record
| CREATOR | Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 424 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |